Merkel cell carcinoma (MCC) is a rare but highly aggressive skin cancer with
neuroendocrine features. MCC pathogenesis is associated with either the presence of …

Merkel cell carcinoma (MCC) is an uncommon primary cutaneous neuroendocrine cancer. It
most commonly presents as an indurated plaque or nodule on sun-damaged skin in elderly …

This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on
areas impacted by recently emerging data, including sections describing MCC risk factors …

Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein-1 (PD-
1)/programmed cell death ligand-1 (PD-L1) frequently induces tumor response in metastatic …

Simple Summary Merkel cell carcinoma (MCC) is a highly aggressive skin cancer and the
second cause of skin cancer death after melanoma. MCC is an immunogenic tumor. In …

Opinion statement Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine
tumor of the skin. Early-stage disease can be cured with surgical resection and radiotherapy …

While uncomplicated cases of nonmelanoma skin cancer can be treated with surgery,
destruction, or topical therapy alone, advanced or neglected cases require more complex …

Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous malignancy of
neuroendocrine origin. It was first described in 1972 by Toker, 1 who named it “trabecular …

Background Merkel cell carcinoma (MCC) guidelines derive from melanoma and do not
recommend baseline cross-sectional imaging for most patients. However, MCC is more …

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of
local recurrence and distant metastasis. Optimal care of this potentially life-threatening …